Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Interruption of mesalamine and reduction of the blood concentration of the active metabolites of azathioprine: possible causes of ulcerative colitis relapse.

× No keyword cloud information.

20 in total

1. Glutathione-S-transferase genotypes and the adverse effects of azathioprine in young patients with inflammatory bowel disease.

Authors: Gabriele Stocco; Stefano Martelossi; Arrigo Barabino; Giuliana Decorti; Fiora Bartoli; Marcella Montico; Annalisa Gotti; Alessandro Ventura
Journal: Inflamm Bowel Dis Date: 2007-01 Impact factor: 5.325

Review 2. Azathioprine and 6-mercaptopurine for maintenance of remission in ulcerative colitis.

Authors: A Timmer; J W D McDonald; J K Macdonald
Journal: Cochrane Database Syst Rev Date: 2007-01-24

3. Sequential evaluation of thiopurine methyltransferase, inosine triphosphate pyrophosphatase, and HPRT1 genes polymorphisms to explain thiopurines' toxicity and efficacy.

Authors: O Palmieri; A Latiano; F Bossa; M Vecchi; R D'Incà; D Guagnozzi; F Tonelli; S Cucchiara; M R Valvano; T Latiano; A Andriulli; V Annese
Journal: Aliment Pharmacol Ther Date: 2007-09-01 Impact factor: 8.171

4. TPMT genotype and the use of thiopurines in paediatric inflammatory bowel disease.

Authors: G Stocco; S Martelossi; A Barabino; M Fontana; P Lionetti; G Decorti; N Malusà; F Bartoli; M Fezzi; T Giraldi; A Ventura
Journal: Dig Liver Dis Date: 2005-09-30 Impact factor: 4.088

5. Azathioprine in paediatric inflammatory bowel disease: an Italian multicentre survey.

Authors: A Barabino; F Torrente; A Ventura; S Cucchiara; M Castro; C Barbera
Journal: Aliment Pharmacol Ther Date: 2002-06 Impact factor: 8.171

6. Simultaneous determination of 6-thioguanine and methyl 6-mercaptopurine nucleotides of azathioprine in red blood cells by HPLC.

Authors: T Dervieux; R Boulieu
Journal: Clin Chem Date: 1998-03 Impact factor: 8.327

7. Monitoring of thiopurine methyltransferase activity in postsurgical patients with Crohn's disease during 1 year of treatment with azathioprine or mesalazine.

Authors: Karin Dilger; Elke Schaeffeler; Milan Lukas; Ulrike Strauch; Hans Herfarth; Ralph Müller; Matthias Schwab
Journal: Ther Drug Monit Date: 2007-02 Impact factor: 3.681

8. Effects of aminosalicylates on thiopurine S-methyltransferase activity: an ex vivo study in patients with inflammatory bowel disease.

Authors: H Xin; C Fischer; M Schwab; U Klotz
Journal: Aliment Pharmacol Ther Date: 2005-05-01 Impact factor: 8.171

9. Mutation in the ITPA gene predicts intolerance to azathioprine.

Authors: A M Marinaki; J A Duley; M Arenas; A Ansari; S Sumi; C M Lewis; M Shobowale-Bakre; L D Fairbanks; J Sanderson
Journal: Nucleosides Nucleotides Nucleic Acids Date: 2004-10 Impact factor: 1.381

10. N-acetyltransferase 1 and 2 genotypes do not predict response or toxicity to treatment with mesalamine and sulfasalazine in patients with ulcerative colitis.

Authors: Elena Ricart; William R Taylor; Edward V Loftus; Dennis O'Kane; Richard M Weinshilboum; William J Tremaine; W Scott Harmsen; Alan R Zinsmeister; William J Sandborn
Journal: Am J Gastroenterol Date: 2002-07 Impact factor: 10.864

2 in total

1. Usefulness of salicylate and thiopurine coprescription in steroid-dependent ulcerative colitis and withdrawal strategies.

Authors: Fernando Bermejo; Javier P Gisbert
Journal: Ther Adv Chronic Dis Date: 2010-05 Impact factor: 5.091

Review 2. Individually administered or co-prescribed thiopurines and mesalamines for inflammatory bowel disease.

Authors: Giovanni-C Actis; Rinaldo Pellicano; Mario Rizzetto; Muhammad Ayoubi; Nicola Leone; Gianfranco Tappero; Paola Pazienza; Floriano Rosina
Journal: World J Gastroenterol Date: 2009-03-28 Impact factor: 5.742

2 in total